Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age Factor”

176 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 176 results

Not applicableStudy completedNCT01682382
What this trial is testing

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascular Age-related Macular Degeneration
Sequenom, Inc. 45
Large-scale testing (Phase 3)Study completedNCT01775618
What this trial is testing

Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A

Who this might be right for
Hemophilia A
Bayer 73
Not applicableStudy completedNCT02464488
What this trial is testing

New Oral Direct Anticoagulants in Patients 80 Years Old and Over : a Population Pharmacokinetics Study

Who this might be right for
Atrial Fibrillation
Hôpital Charles Foix 232
Not applicableStudy completedNCT03719703
What this trial is testing

Health in Childhood Following Assisted Reproductive Technology

Who this might be right for
ARTIVFCardiovascular Risk Factor+2 more
Anja Bisgaard Pinborg 606
Not applicableLooking for participantsNCT07249216
What this trial is testing

Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting

Who this might be right for
Age Related Macular Degeneration
Singapore National Eye Centre 117
Testing effectiveness (Phase 2)WithdrawnNCT03446144
What this trial is testing

Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge Related Macular Degeneration
Ionis Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)UnknownNCT00002219
What this trial is testing

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

Who this might be right for
HIV Infections
Gilead Sciences 36
Not applicableStudy completedNCT03840330
What this trial is testing

High-intensity Training for Improving Physical Performance of Aged Women

Who this might be right for
AgingHealthyCardiovascular Risk Factor+1 more
Universidad de Almeria 54
Testing effectiveness (Phase 2)Ended earlyNCT02348359
What this trial is testing

X-82 to Treat Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration (AMD)Macular DegenerationExudative Age-related Macular Degeneration+5 more
Tyrogenex 157
Not applicableStudy completedNCT02210013
What this trial is testing

Differences in Ovarian Aging Between Caucasian and Indian Women

Who this might be right for
Age of the Patients and the Body Mass Index in Both Groups
IVI Madrid 400
Not applicableUnknownNCT00926861
What this trial is testing

Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD

Who this might be right for
Dry Age-related Macular DegenerationDetachment of the Posterior Hyaloid
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 320
Not applicableStudy completedNCT02080923
What this trial is testing

A Brief Intervention to Prevent Adolescent Dating Aggression Perpetration

Who this might be right for
Offensive AggressionSexual AggressionDating Violence Perpetration and Victimization
Boston University 220
Early research (Phase 1)Study completedNCT03387566
What this trial is testing

Single Intravitreal Injection HB002.1M in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Huabo Biopharm Co., Ltd. 21
Not applicableUnknownNCT03120884
What this trial is testing

Intracytoplasmic Sperm Injection in Non-male Factor Infertility in Advanced Maternal Age

Who this might be right for
Infertility, FemaleART
International Peace Maternity and Child Health Hospital 1,422
Large-scale testing (Phase 3)Study completedNCT03034772
What this trial is testing

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular DegenerationWet Macular Degeneration
Wills Eye 52
Large-scale testing (Phase 3)Study completedNCT00509795
What this trial is testing

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 1,217
Large-scale testing (Phase 3)Study completedNCT00129363
What this trial is testing

Study to Evaluate the Safety of Twice Daily Oral Carvedilol

Who this might be right for
Congestive Heart Failure
Shaddy, Robert, M.D. 75
Large-scale testing (Phase 3)Study completedNCT00037557
What this trial is testing

Study Evaluating rFIX; BeneFIX in Severe Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 20
Not applicableUnknownNCT01735539
What this trial is testing

Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance With Age; the Role of Amino Acids in Modulating Muscle Metabolism

Who this might be right for
Old Age (Focus; Not a Recognized Condition)
University of Nottingham 40
Large-scale testing (Phase 3)Study completedNCT05666804
What this trial is testing

Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

Who this might be right for
Macular Polypoidal Choroidal Vasculopathy (PCV)
Novartis Pharmaceuticals 148
Load More Results